While exome sequencing has shown its value in the clinic relative to candidate gene panel sequencing, yields remain stubbornly low, at slightly less than half of evaluated cases. Overlap of clinical signs, such as in intellectual disability, as well as the sheer volume of disorders, contribute to the diagnostic complexity. The analytic challenge lends itself well to the development of bioinformatics tools, and several software programs that aim to assist diagnostic accuracy and overall yield are now in use. A model program to increase access to genetic testing in China has demonstrated a large impact on patient management. The finding offers a potential model for increasing access while expanding physician awareness of genetic testing in patient management. Currently, China lacks trained medical genetics professionals and the high cost of testing has created a wide disparity in access. The few medical geneticists practicing in China were mainly trained abroad. Genetic counseling as a profession does not exist in China, and follow-up genetic testing for suspected inherited disorders does not exist in routine medical practice. In a report detailed in this issue, a group of academic medical geneticists practicing in urban settings evaluated the clinical utility of a lower-cost solution to expensive exome sequencing. The research team offered proband-only medical exome sequencing to ordering physicians who lacked the resources and training for the diagnostic task. Over a year and a half, from April 2015 to December 2016, the geneticists took 1323 referrals at Shanghai Children's Medical Center. The overall diagnostic rate for this unselected patient population was 28.8%. Skin, kidney, skeletal, gastroenteric, and endocrine diseases, as well as metabolic disorders and multiple malformation, comprised the range of diagnoses. As a result of these diagnoses, patients received genetic counseling, referral for systemic evaluation, and new treatment or change of treatment. After receiving a molecular diagnosis, 28% (46/ 164) of the patients had physical examinations focusing on various organs or systems, and 45.1% (74) of patients' clinical management changed based on the molecular findings. The study shows that nations underresourced in clinical genetics professionals can offer genetic testing to larger numbers of patients through innovative use of existing technology. -Karyn Hede, News Editor
